The Predictive Value of Biochemical Markers of Bone Turnover for Bone Mineral Density in Early Postmenopausal Women Treated with Hormone Replacement or Calcium Supplementation

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 6, 1997, Pages 1904-1910

  Rosen, Clifford J ^a   Chesnut III, Charles H ^b   Mallinak, Nancy J S ^c  

^a ST JOSEPH HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Ostex International Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALCIUM;

ADULT; ARTICLE; BONE; BONE DENSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; POSTMENOPAUSE; PREDICTION AND FORECASTING; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADULT; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; CALCIUM; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS; SINGLE-BLIND METHOD;

EID: 0031156595     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.6.1904     Document Type: Article

References (18)

1. Manolagas SC, Jilka RL. 1995 Emerging insights into the pathophysiology of osteoporosis. N Engl J Med. 332:305-311.
2. Mundy GR. 1987 Bone resorption and turnover in health and disease. Bone. 8:S9-S16.
3. Bush TL, Wells HB, James MK, et al. 1996 Effects of hormone replacement therapy on bone mineral density. JAMA. 276:1389-1346.
4. Chesnut III CH, Bell NH, Clark GS, et al. 1997 Hormone replacement therapy in postmenopausal women:urinary N-telopeptide of type I collagen monitors theapeutic effect and predicts response of bone mineral density. Am J Med. 102;29-37.
5. Ebeling PR, Atley LM, Guthrie JR, et al. 1996 Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab. 81:3366-3371.
6. Rosen CJ. 1996 Biochemical markers of bone turnover. In: Rosen CJ, ed. Osteoporosis: diagnostic and therapeutic principles. Tonawa: Humana Press; 129-141.
7. Johnson J, Dawson-Hughes B. 1991 Precison and stability of dual energy x-ray absorptiometry measurements. Calcif Tissue Int. 49:174-178.
8. Hanson DA, Weis MAE, Bollen AM, Eyre D. 1992 A specific immunoassay for monitoring bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res. 7:1251-1258.
9. Seyedin SM, Kung VT, Daniloff YN. 1993 Immunoassay for urinary pyridinoline: the new marker of bone resorption. J Bone Miner Res. 8:635-641.
10. Gundberg GM, Hauschka PV, Lian JB, Gallop PM. 1984 Osteocalcin: isolation, characterization, and detection. Methods Enzymol. 107:517-543.
11. Farley JR, Chestnut CH, Baylink DJ. 1981 Improved method for determination of serum alkaline phosphatase of skeletal origin. Clin Chem. 27:2002-2007.
12. Farley JR, Hall SL, Herring S. 1993 Reference standards for quantification of skeletal alkaline phosphatase activity in serum by heat inactivation and lectin precipitation. Clin Chem. 39:1878-1884.
13. Gertz BJ, Saho P, Hanson DA, et al. 1994 Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine. J Bone Miner Res. 9:135-140.
14. Delmas PD, Wahner HW, Mann KG, Riggs BL. 1983 Assessment of bone turnover in postmenopausal osteoporosis by measurement of bone gla protein. J Lab Clin Med. 102:470-476.
15. Civitelli R, Gonelli S, Sachei F. 1988 Bone turnover in postmenopausal osteoporosis: effect of calcitonin treatment. J Clin Invest. 82:1268-1274.
16. Lindsay R, Tohme JF. 1991 Estrogen treatment of patients with postmenopausal osteoporosis. Obstet Gynecol. 76:290-295.
17. Lufkin EJ, Wasner HW, O'Fallon WM. 1992 Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med. 117:1-9.
18. Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD. 1994 Comparison of new biochemical markers of bone turnover in late postmenopausal women in response to alendronate treatment. J Clin Endocrinol Metab. 79:1693-1670.